TNFSF13 Antikörper (AA 16-108, AA 105-250)
-
- Target Alle TNFSF13 Antikörper anzeigen
- TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Bindungsspezifität
- AA 16-108, AA 105-250
-
Reaktivität
- Human, Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TNFSF13 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Produktmerkmale
- A-Proliferation-inducing ligand| TNFSF 13| CD256,APRIL monoclonal antibody (Sacha-2)
- Aufreinigung
- Purified from concentrated hybridoma tissue culture supernatant.
- Immunogen
- Recombinant human APRIL (aa 105-250) fused to human ACRP30headless (aa 16-108)
- Klon
- Sacha-2
- Isotyp
- IgG2a
- Top Product
- Discover our top product TNFSF13 Primärantikörper
-
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (Internal Region) antibody
TNFSF13 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (AA 105-250) antibodyTNFSF13 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 2C2C11 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (AA 105-247) antibodyTNFSF13 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (AA 93-233) antibodyTNFSF13 Reaktivität: Human WB, FACS, IP, ICC, IHC (p) Wirt: Maus Monoclonal Aprily-8 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (AA 1-247) antibodyTNFSF13 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal G3 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (Internal Region) antibodyTNFSF13 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (Internal Region) antibodyTNFSF13 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (AA 105-250), (AA 16-108) antibodyTNFSF13 Reaktivität: Human, Maus FACS, ICC Wirt: Ratte Monoclonal Sacha-1 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (AA 105-250) antibodyTNFSF13 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13) (Center) antibodyTNFSF13 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Schwein WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- ELISA (capture)Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid. In PBS containing 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- +4°C Stable for at least 6 months after receipt when stored at +4°C undiluted.
- Haltbarkeit
- 6 months
-
- Target
- TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
- Andere Bezeichnung
- APRIL (TNFSF13 Produkte)
- Synonyme
- APRIL antikoerper, CD256 antikoerper, TALL-2 antikoerper, TALL2 antikoerper, TRDL-1 antikoerper, ZTNF2 antikoerper, 2310026N09Rik antikoerper, April antikoerper, Tall2 antikoerper, Trdl1 antikoerper, SLAN antikoerper, ANP32B antikoerper, april antikoerper, tnf13 antikoerper, TNLG7B antikoerper, TNF superfamily member 13 antikoerper, tumor necrosis factor (ligand) superfamily, member 13 antikoerper, acidic leucine-rich nuclear phosphoprotein 32 family member B antikoerper, TNFSF13 antikoerper, Tnfsf13 antikoerper, LOC494442 antikoerper, tnfsf13 antikoerper
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-
